Your browser doesn't support javascript.
loading
[Analysis on the clinical efficacy and adverse reactions of blinatumomab for the treatment of relapsed/refractory acute lymphoblastic leukemia].
Shi, Y J; Han, Y; Wang, Y; Mao, D F; Zhang, J L; Xi, R; Bai, H; Wu, T.
Affiliation
  • Shi YJ; Department of Hematology, the 940th Hospital of Joint Logistics Support Force of Chinese People's Liberation Amy, Lanzhou 730050, China.
  • Han Y; Department of Hematology, the 940th Hospital of Joint Logistics Support Force of Chinese People's Liberation Amy, Lanzhou 730050, China.
  • Wang Y; Department of Hematology, the 940th Hospital of Joint Logistics Support Force of Chinese People's Liberation Amy, Lanzhou 730050, China.
  • Mao DF; Department of Hematology, the 940th Hospital of Joint Logistics Support Force of Chinese People's Liberation Amy, Lanzhou 730050, China.
  • Zhang JL; Department of Hematology, the 940th Hospital of Joint Logistics Support Force of Chinese People's Liberation Amy, Lanzhou 730050, China.
  • Xi R; Department of Hematology, the 940th Hospital of Joint Logistics Support Force of Chinese People's Liberation Amy, Lanzhou 730050, China.
  • Bai H; Department of Hematology, the 940th Hospital of Joint Logistics Support Force of Chinese People's Liberation Amy, Lanzhou 730050, China.
  • Wu T; Department of Hematology, the 940th Hospital of Joint Logistics Support Force of Chinese People's Liberation Amy, Lanzhou 730050, China.
Zhonghua Xue Ye Xue Za Zhi ; 44(6): 516-519, 2023 Jun 14.
Article in Zh | MEDLINE | ID: mdl-37550212

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Precursor B-Cell Lymphoblastic Leukemia-Lymphoma / Antibodies, Bispecific / Precursor Cell Lymphoblastic Leukemia-Lymphoma / Antineoplastic Agents Limits: Humans Language: Zh Journal: Zhonghua Xue Ye Xue Za Zhi Year: 2023 Document type: Article Affiliation country: China

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Precursor B-Cell Lymphoblastic Leukemia-Lymphoma / Antibodies, Bispecific / Precursor Cell Lymphoblastic Leukemia-Lymphoma / Antineoplastic Agents Limits: Humans Language: Zh Journal: Zhonghua Xue Ye Xue Za Zhi Year: 2023 Document type: Article Affiliation country: China